Form 4: Vir Biotechnology Director Receives Equity Grant

Director Jeffrey S. Hatfield was granted 8,000 restricted stock units and 16,000 stock options by Vir Biotechnology.

Summary

• Director Jeffrey S. Hatfield acquired 8,000 restricted stock units (RSUs) on May 27, 2026.
• The director was also granted 16,000 stock options with an exercise price of $9.10.
• Both the RSUs and the stock options are scheduled to vest in full on May 27, 2027.
• Following these transactions, the director's total beneficial ownership of common stock is 39,806 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard retention and incentive structure for board members.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of options and vesting of RSUs.

Risks

• Market volatility affecting the value of equity grants.
• Performance risk associated with the company's ability to meet milestones required for long-term stock appreciation.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard practice in the biotechnology sector to ensure board alignment with long-term corporate strategy and shareholder value creation.

Comparison to Industry Standards

• The use of RSUs and stock options as part of director compensation is consistent with standard practices for mid-cap biotechnology firms.
• Vesting periods of one year for director equity are common in the industry to ensure retention.

Stakeholder Impact

• Minor dilution impact on existing shareholders upon future exercise of options.

Next Steps

• Vesting of equity grants on May 27, 2027.

Key Dates

Keywords

Vir Biotechnology, VIR, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation